ACTIVE

APOTHEEK HAEMELS

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result
61,9 k €
-4,5 %over 1 year
Gross margin
137 k €
+6,6 %over 1 year
Equity
204,5 k €
+43,4 %over 1 year

Identity

Source · BCE/KBO

APOTHEEK HAEMELS is a Private limited company incorporated in 2006. Its main activity is: Manufacture of other organic basic chemicals. Its registered office is in Tervuren.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0880.313.206
Incorporation
17/03/2006
Legal form
Private limited company
Registered office
Sterrebeeklaan 32
3080 Tervuren · FlandreSee on map
Contributed capital
6 200,00 €
Latest accounts
31/12/2025
Signals
ProfitableSolid equityLow riskPositive cashflowPositive EBITDA

Financials

Source · NBB, 19 filings

Trend over 19 financial years

20252024202320222021
Income statement
Gross margin137 k €128,5 k €141 k €114,3 k €108,5 k €
EBITDA133,9 k €125,4 k €137,2 k €110,7 k €105,3 k €
Operating result86,2 k €78,9 k €90,7 k €64,4 k €69,7 k €
Net result61,9 k €64,9 k €77,3 k €44,8 k €54,1 k €
Balance sheet
Equity204,5 k €142,5 k €104,7 k €77,4 k €47,5 k €
Total assets541,4 k €581,9 k €610,3 k €634 k €675,2 k €
Cash91,9 k €121,4 k €83,4 k €84,1 k €82,2 k €
Debts334,2 k €436,3 k €502,7 k €553,8 k €624,3 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 1 ended

Active mandates

TERVEST

Director · 0500.522.275

Represented by Kris Haemels

Active

Ended mandates

Kris Haemels

Manager · since 17 mars 2006

Ended

Other companies at this address

Sterrebeeklaan 32 3080 Tervuren
CompanyCBE no.
KRITO PHARMA● Active
0500.718.255
TERVEST● Active
0500.522.275

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date01/06/202613/06/202503/06/202401/06/202302/06/202228/05/2021
General meeting29/05/202630/05/202531/05/202426/05/202327/05/202228/05/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 19 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202529/05/202601/06/2026DutchPDF
Abridged model31/12/202430/05/202513/06/2025DutchPDF
Abridged model31/12/202331/05/202403/06/2024DutchPDF
Abridged model31/12/202226/05/202301/06/2023DutchPDF
Abridged model31/12/202127/05/202202/06/2022DutchPDF
Abridged model31/12/202028/05/202128/05/2021DutchPDF
Abridged model31/12/201919/06/202025/08/2020DutchPDF
Abridged model31/12/201821/06/201928/06/2019DutchPDF
Abridged model31/12/201725/05/201825/06/2018DutchPDF
Abridged model31/12/201626/05/201708/06/2017DutchPDF
Abridged model31/12/201527/05/201607/07/2016DutchPDF
Abridged model31/12/201429/05/201521/08/2015DutchPDF
Abridged model31/12/201330/05/201413/06/2014DutchPDF
Abridged model31/12/201231/05/201313/06/2013DutchPDF
Abridged model31/12/201115/06/201212/07/2012DutchPDF
Abridged model31/12/201017/06/201122/08/2011DutchPDF
Abridged model31/12/200928/05/201010/06/2010DutchPDF
Abridged model31/12/200829/05/200929/06/2009DutchPDF
Abridged model31/12/200720/06/200831/07/2008DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 1 ended

Active mandates

TERVEST

Director · 0500.522.275

Represented by Kris Haemels

Active

Ended mandates

Kris Haemels

Manager · since 17 mars 2006

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates06/12/2022
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM - DIVERSEN - DOEL - ONTSLAGEN - BENOEMINGEN
    PDF
  • Other06/04/2006
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 202561,9 k €↓
  2. 2024
    Annual accounts 202464,9 k €↓
  3. 2023
    Annual accounts 202377,3 k €↑
  4. 2022
    Annual accounts 202244,8 k €↓
  5. 2022
    Name changeHAEMELS APOTHEEK
  6. 2021
    Annual accounts 202154,1 k €↑
  7. 2021
    Name changeApotheek Haemels
  8. 2020
    Annual accounts 202042,2 k €↑
  9. 2019
    Annual accounts 201930,3 k €↓
  10. 2018
    Annual accounts 201879,6 k €↑
  11. 2017
    Annual accounts 201742,6 k €↑
  12. 2016
    Annual accounts 201637,3 k €↑
  13. 2015
    Annual accounts 201521,1 k €↑
  14. 2014
    Annual accounts 20144,9 k €↑
  15. 2013
    Annual accounts 2013-6,1 k €↓
  16. 2012
    Annual accounts 20123,8 k €↓
  17. 2011
    Annual accounts 20118 k €↑
  18. 2010
    Annual accounts 2010-14,4 k €↓
  19. 2009
    Annual accounts 200916,6 k €↑
  20. 2008
    Annual accounts 20083,1 k €↑
  21. 2007
    Annual accounts 2007-113,8 k €
  22. 17/03/2006
    IncorporationPrivate limited company